Pustular psoriasis and arthropathy in a patient with HIV infection. Clinical case

Abstract

The article presents a clinical case of pustular psoriasis and arthropathy in a patient with HIV infection. The diagnosis of psoriasis was confirmed by morphological examination. Signs of arthropathy were confirmed by X-Ray: presence of oligoarthritis of the distal interphalangeal joints of the fingers and feet was seen. Dactylitis severity ― 2–3 points, the Ritchie index ― 2, DLQI ― 28. The clinical course of psoriasis and its treatment in HIV-infected patients was considered after taking into account the data from literature and the patients current condition and observation. The above observation of a combination of several clinical forms of psoriasis (vulgar, pustular and arthropathy) in patients with HIV infection is an illustration of the features of the course and comorbidity of chronic dermatosis and AIDS, due to the influence of the infectious process, immunosuppression and ART. The development of pustular form and arthropathy creates the additional challenge of prescribing basic systemic treatment for severe and complicated psoriasis in an HIV-infected patient due to the presence of contraindications due to comorbidity. The glucocorticosteriod selected by the committee was effective on the skin and joint pathological processes, without having any negative impact on the course and treatment of the HIV infection. Such cases require further study and development of methods for the treatment of patients with comorbidity and their inclusion in an additional section in the clinical recommendations for the diagnosis and treatment of psoriasis.

Keywords

psoriasis / HIV infection / pustular psoriasis / psoriatic arthropathy / comorbidity / clinical features / immunosuppression / treatment

References

[1] Galegov GA, Lviv DK. HIV infection: clinic, diagnosis, treatment. Epidemiology of infectious diseases. 2003;(3):62–64. (In Russ).

[2] Галегов Г.А., Львов Д.К. ВИЧ-инфекция: клиника, диагностика, лечение//Эпидемиология инфекционных болезней. 2003. № 3. С. 62–64.

[3] Lowell GA, Katz C, Gilchrist B, et al. Fitzpatrick’s dermatology in clinical practice. Vol. 2. Second edition. Moscow : Binom; 2016. Р. 1425–2118. (In Russ).

[4] Лоуэлл Г.А., Кац С.И., Джилкрест Б.А., и др. Дерматология Фицпатрика в клинической практике. Т. 2. Второе изд. Москва : Бином, 2016. С. 1425–2118.

[5] Katsambas FD, Lotti TM. European guidelines for the treatment of dermatological diseases. Moscow: MEDpress-inform; 2014. Р. 392–406. (In Russ).

[6] Кацамбас Ф.Д., Лотти Т.М. Европейское руководство по лечению дерматологических заболеваний. Москва : МЕДпресс-информ, 2014. С. 392–406.

[7] Kubanova AA. Federal clinical recommendations. Dermatovenerology 2015: Skin diseases. Sexually transmitted infections. Moscow: Delovoi ehkspress; 2016. 786 p. (In Russ).

[8] Кубанова А.А. Федеральные клинические рекомендации. Дерматовенерология 2015: Болезни кожи. Инфекции, передаваемые половым путем. Москва : Деловой экспресс, 2016. 786 с.

[9] Serdyukova EA, Rusinov VI, Mironova YV, Markelov VV. Skin diseases on the background of immunodeficiency caused by HIV infection. Immunology, allergology, infectology. 2012;(2):66–69. (In Russ).

[10] Сердюкова Е.А., Русинов В.И., Миронова Ю.В., Маркелов В.В. Заболевания кожи на фоне иммунодефицита, обусловленного ВИЧ-инфекцией//Иммунология, аллергология, инфектология. 2012. № 2. С. 66–69.

[11] Statistics on HIV infection in Russia [Electronic resource]. O-spide.ru. Official Internet portal of the Ministry of Health of the Russian Federation on HIV prevention/AIDS. (In Russ). Available from: https://o-shide.ru/officially/statistika-po-vich-infekcii-v-rossii

[12] Статистика по ВИЧ-инфекции в России [электронный ресурс]. O-spide.ru. Официальный интернет-портал Минздрава России о профилактике ВИЧ/СПИД. Available from: http://o-shide.ru/officially/statistika-po-vich-infekcii-v-rossii

[13] Gobena DL, Guzey TN. Diseases of the skin and mucous membranes in patients with HIV infection. Clinical Dermatology and Venereology. 2011;9(3):19–22. (In Russ).

[14] Гобена Д.Л., Гузей Т.Н. Заболевания кожи и слизистых оболочек у больных с ВИЧ-инфекцией//Клиническая дерматология и венерология. 2011. Т. 9, № 3. С. 19–22.

[15] Dubensky VV, Balashova IY, Maksimov MO, et al. Lesion of the skin and mucous membranes in a patient with HIV infection. Clinical dermatology and venereology. 2004;(4):25–27. (In Russ).

[16] Дубенский В.В., Балашова И.Ю., Максимов М.О., и др. Поражение кожи и слизистых оболочек у больного инфекцией ВИЧ//Клиническая дерматология и венерология. 2004. № 4. C. 25–27.

[17] Yutskovsky AD, Bondar GN, Kornienko AN. Skin lesions in an HIV-infected child: the effectiveness of antiretroviral therapy. Clinical Dermatology and Venereology. 2009;7(3):32–34. (In Russ).

[18] Юцковский А.Д., Бондарь Г.Н., Корниенко А.Н. Кожные поражения у ВИЧ-инфицированного ребенка: эффективность антиретровирусной терапии//Клиническая дерматология и венерология. 2009. Т. 7, № 3. C. 32–34.

[19] Cedeno-Laurent F, Gómez-Flores M, Mendez N, et al. New insights into HIV-1-primary skin disorders. J Int AIDS Soc. 2011;(14):5. doi: 10.1186/1758-2652-14-5

[20] Cedeno-Laurent F., Gómez-Flores M., Mendez N., et al. New insights into HIV-1-primary skin disorders//J Int AIDS Soc. 2011. Vol. 14. Р. 5. doi: 10.1186/1758-2652-14-5

[21] Abidova ZM, Ikramova NJ, Tsoi MR. The case of shingles in an HIV-infected patient. Clinical dermatology and venereology: 2004;(1):28–29. (In Russ).

[22] Абидова З.М., Икрамова Н.Дж., Цой М.Р. Случай опоясывающего лишая у ВИЧ-инфицированной больной//Клиническая дерматология и венерология. 2004. № 1. C. 28–29.

[23] Molochkov VA, Snarskaya ES. Giant pointed condyloma of Buschke-Levenshtein in a patient with HIV infection. Russian Journal of Skin and Venereal Diseases. 2006;(5):14–16. (In Russ).

[24] Молочков В.А., Снарская Е.С. Гигантская остроконечная кондилома Бушке-Левенштейна у пациента с ВИЧ-инфекцией//Российский журнал кожных и венерических болезней. 2006. № 5. C. 14–16.

[25] Khashieva FN, Potekaev NN, Kravchenko AV, et al. B. Clinic of simple and herpes zoster in patients with HIV infection. Clinical dermatology and venereology. 2004;(4):8–10. (In Russ).

[26] Хашиева Ф.Н., Потекаев Н.Н., Кравченко А.В., и др. Клиника простого и опоясывающего герпеса у больных ВИЧ-инфекцией//Клиническая дерматология и венерология. 2004. № 4. C. 8–10.

[27] Evdokimov EY, Sundukov AV. Psoriasis in HIV-infected patients: clinical and laboratory assessment, approaches to therapy. Russian Journal of Skin and Venereal Diseases. 2017;20(4):227–231. (In Russ). doi: 10.18821/1560-9588-2017-20-4-227-231

[28] Евдокимов Е.Ю., Сундуков А.В. Псориаз у ВИЧ-инфицированных больных: клинико-лабораторная оценка, подходы к терапии//Российский журнал кожных и венерических болезней. 2017. Т. 20, № 4. C. 227–231. doi: 10.18821/1560-9588-2017-20-4-227-231

[29] Menon K, Van Voorhees AS, Bebo BF, et al. Psoriasis in patients with HIV infection: From the Medical Board of the National Psoriasis Foundation. Acad J Am Dermatol. 2010;62(2):291–299. doi: 10.1016/j.jaad.2009.03.047

[30] Menon K., Van Voorhees A.S., Bebo B.F., et al. Psoriasis in patients with HIV infection: From the Medical Board of the National Psoriasis Foundation//Acad J Am Dermatol. 2010. Vol. 62, N 2. Р. 291–299. doi: 10.1016/j.jaad.2009.03.047

[31] Mikhail M, Weinberg JM, Smith BL. Successful treatment with etanercept of von Zumbusch pustular psoriasis in a patient with human immunodeficiency virus. Arch Dermatol. 2008;144 (4):453–456. doi: 10.1001/archderm.144.4.453

[32] Mikhail M., Weinberg J.M., Smith B.L. Successful treatment with etanercept of von Zumbusch pustular psoriasis in a patient with human immunodeficiency virus//Arch Dermatol. 2008. Vol. 144, N 4. Р. 453–456. doi: 10.1001/archderm.144.4.453

[33] Morar N, Willis-Owen SA, Maurer T, Bunker CB. HIV associated psoriasis: pathogenesis, clinical features, and management. Lancet Infect Dis. 2010;10(7):470–476. doi: 10.1016/S1473-3099(10)70101-8

[34] Morar N., Willis-Owen S.A., Maurer T., Bunker C.B. HIV associated psoriasis: pathogenesis, clinical features, and management//Lancet Infect Dis. 2010. Vol. 10, N 7. Р. 470–476. doi: 10.1016/S1473-3099(10)70101-8

[35] Patel RV. Psoriasis in the patient with human immunodeficiency virus, part 1. Cutis. 2008;82(2):117–122.

[36] Patel R.V. Psoriasis in the patient with human immunodeficiency virus, part 1//Cutis. 2008. Vol. 82, N 2. Р. 117–122.

[37] Batkaeva NV, Batkaev EA, Gitinova MM, et al. Features of diseases of the cardiovascular system in patients with severe and moderate-severe forms of psoriasis. Bulletin of the RUDN. 2018;22(1):92–101. (In Russ). doi: 10.22363/2313-0245-2018-22-1-92-101

[38] Баткаева Н.В., Баткаев Э.А., Гитинова М.М., и др. Особенности заболеваний сердечно-сосудистой системы у больных тяжелыми и среднетяжелыми формами псориаза//Вестник РУДН. 2018. Т. 22, № 1. С. 92–101. doi: 10.22363/2313-0245-2018-22-1-92-101

[39] Batyrshina SV, Sadykova FG. Comorbid conditions in patients with psoriasis. Practical medicine. 2014;(8):32–35. (In Russ).

[40] Батыршина С.В., Садыкова Ф.Г. Коморбидные состояния у больных псориазом//Практическая медицина. 2014. № 8. С. 32–35.

[41] Gulaliev DM. The combination of scleroderma and psoriasis. Clinical Dermatology and Venereology. 2015;14(4):20–22. (In Russ).

[42] Гюльалиев Д.М. Сочетание склеродермии и псориаза//Клиническая дерматология и венерология. 2015. Т. 14, № 4. С. 20–22.

[43] Dubensky VV, Nekrasova EG, Muravyeva ES, et al. Psoriasis in a patient with vitiligo. Russian Journal of Skin and Venereal Diseases. 2017;20(4):232–233. (In Russ). doi: 10.18821/1560-9588-2017-20-4-232-233

[44] Дубенский В.В., Некрасова Е.Г., Муравьева Е.С., и др. Псориаз у больной витилиго//Российский журнал кожных и венерических болезней. 2017. Т. 20, № 4. С. 232–233. doi: 10.18821/1560-9588-2017-20-4-232-233

[45] Dubensky VV, Nekrasova EG, Alexandrova OA, Muravyeva ES. Vulgar psoriasis and squamous cell carcinoma in a patient with discoid lupus erythematosus. Bulletin of Dermatology and Venereology. 2020;96(4):63–69. (In Russ). doi: 10.25208/vdv1120-2020-96-4-60-66

[46] Дубенский В.В., Некрасова Е.Г., Александрова О.А., Муравьева Е.С. Вульгарный псориаз и плоскоклеточный рак у больного дискоидной красной волчанкой//Вестник дерматологии и венерологии. 2020. Т. 96, № 4. С. 60–66. doi: 10.25208/vdv1120-2020-96-4-60-66

[47] Kovkova GY, Shabanova AA, Matusevich SL, Bakhlykova EA. The combination of psoriasis and vulgar pemphigus in one patient: a clinical observation. Clinical dermatology and Venereology. 2018;(1):34–38. (In Russ). doi: 10.17116/klinderma201817134-38

[48] Ковкова Г.Ю., Шабанова А.А., Матусевич С.Л., Бахлыкова Е.А. Сочетание псориаза и вульгарной пузырчатки у одного больного: клиническое наблюдение//Клиническая дерматология и венерология. 2018. Т. 17, № 1. С. 34–38. doi: 10.17116/klinderma201817134-38

[49] Tlish MM, Katkhanova OA, Naatyzh ZY, et al. Psoriasis in a patient with ichthyosis. Russian Journal of Skin and Venereal Diseases. 2015;18(2):34–39. (In Russ).

[50] Тлиш М.М., Катханова О.А., Наатыж Ж.Ю., и др. Псориаз у больного ихтиозом//Российский журнал кожных и венерических болезней. 2015. Т. 18, № 2. С. 34–39.

[51] Olisova OY, Garanyan LG. Epidemiology, etiopathogenesis and comorbidity in psoriasis-new facts. Russian Journal of Skin and Venereal Diseases. 2017;20(4):214–219. (In Russ). doi: 10.18821/1560-9588-2017-20-4-214-219

[52] Олисова О.Ю., Гаранян Л.Г. Эпидемиология, этиопатогенез и коморбидность при псориазе ― новые факты//Российский журнал кожных и венерических болезней. 2017. Т. 20, № 4. С. 214–219. doi: 10.18821/1560-9588-2017-20-4-214-219

[53] Langan SM, Seminara NM, Shin DV, et al. Prevalence of metaboloc syndrom in patients with psoriasis: a population – based study in the United Kingdom. J Invest Dermatol. 2012;132(3 Pt 1):556–562. doi: 10.1038/jid.2011.365

[54] Langan S.M., Seminara N.M., Shin D.V., et al. Prevalence of metaboloc syndrom in patients with psoriasis: a population – based study in the United Kingdom//J Invest Dermatol. 2012. Vol. 132, N 3, Pt 1. Р. 556–562. doi: 10.1038/jid.2011.365

[55] Yang YW, Keller JJ, Lin HC. Medical comorbidity associated with psoriasis in adults: a population – based study. Br J Dermatol. 2011;165(5):1037–1043. doi: 10.1111/j.1365-2133.2011

[56] Yang Y.W., Keller J.J., Lin H.C. Medical comorbidity associated with psoriasis in adults: a population ― based study//Br J Dermatol. 2011. Vol. 165, N 5. Р. 1037–1043. doi: 10.1111/j.1365-2133.2011

[57] Oleynik AF, Fazylov VK. Reasons for the immunological ineffectiveness of antiretroviral therapy in patients with HIV infection. Kazan Medical Journal. 2014;95(4):581–588. (In Russ).

[58] Олейник А.Ф., Фазылов В.Х. Причины иммунологической неэффективности антиретровирусной терапии пациентов с ВИЧ-инфекцией//Казанский медицинский журнал. 2014. Т. 95, № 4. С. 581–588.

[59] Khairutdinov VR, Belousova IE, Samtsov AV. Immune pathogenesis of psoriasis. Bulletin of Dermatology and Venereology. 2016;(4):20–26. (In Russ).

[60] Хайрутдинов В.Р., Белоусова И.Э., Самцов А.В. Иммунный патогенез псориаза//Вестник дерматологии и венерологии. 2016. № 4. С. 20–26.

[61] De Socio VL, Simonetti S, Stagni G. Clinical Improvement of Psoriasis in an AIDS patient effectively treated with combination antiretroviral therapy. Scand J Infect Dis. 2006;38(1):74–75. doi: 10.1080/00365540500322296

[62] De Socio V.L., Simonetti S., Stagni G. Clinical Improvement of Psoriasis in an AIDS patient effectively treated with combination antiretroviral therapy//Scand J Infect Dis. 2006. Vol. 38, N 1. Р. 74–75. doi: 10.1080/00365540500322296

[63] Mahil SK, Capon F, Barker JN. Update on psoriasis immunopathogenesis and targeted immunotherapy. Semin Immunopathol. 2016;38(1):11–27. doi: 10.1007/s00281-015-0539-8

[64] Mahil S.K., Capon F., Barker J.N. Update on psoriasis immunopathogenesis and targeted immunotherapy//Semin Immunopathol. 2016. Vol. 38, N 1. Р. 11–27. doi: 10.1007/s00281-015-0539-8

[65] Asumalahti K, Laitinen T, Itkonen-Vatjus R, et al. A candidate Gene for psoriasis near HLA-C, HCR (Pg8), is highly polymorphic with a disease-associated susceptibility allele. Hum Mol genet. 2000;9(10):1533–1542. doi: 10.1093/hmg/9.10.1533

[66] Asumalahti K., Laitinen T., Itkonen-Vatjus R, et al. A candidate Gene for psoriasis near HLA-C, HCR (Pg8), is highly polymorphic with a disease-associated susceptibility allele//Hum Mol Genet. 2000. Vol. 9, N 10. Р. 1533–1542. doi: 10.1093/hmg/9.10.1533

[67] Lowes MA, Suárez-Fariñas M, Krueger JG. Immunology of psoriasis. Annu Rev Immunol. 2014;(32):227–255. doi: 10.1146/annurev-immunol-032713-120225

[68] Lowes M.A., Suárez-Fariñas M., Krueger J.G. Immuno- logy of psoriasis//Annu Rev Immunol. 2014. N 32. Р. 227–255. doi: 10.1146/annurev-immunol-032713-120225

[69] Piruzian ES, Sobolev VV, Abdeev RM, et al. Study of the molecular mechanisms of pathogenesis of immunological inflammatory disorders using psoriasis as an example. Acta naturae. 2009;1(3):139–150.

[70] Piruzian E.S., Sobolev V.V., Abdeev R.M., et al. Study of the molecular mechanisms of pathogenesis of immunological inflammatory disorders using psoriasis as an example//Acta Naturae. 2009. Vol. 1, N 3. Р. 139–150.

[71] Butov YS. Dermatovenerology. National leadership. Short edition. Moscow : GEOTAR-Media; 2017. 896 р. (In Russ).

[72] Бутов Ю.С. Дерматовенерология. Национальное руководство. Краткое издание. Москва : ГЭОТАР-Медиа, 2017. 896 с.

[73] Potekaev NN, Kruglova LS. Psoriatic disease. Moscow: MDV; 2014. 298 p. (In Russ).

[74] Потекаев Н.Н., Круглова Л.С. Псориатическая болезнь. Москва : МДВ, 2014. 298 с.

[75] Kochergin NG, Smirnova LM, Kochergin SN. Results of the first World Conference on psoriasis and psoriatic arthritis. Russian Medical Journal. 2006;(15):1151. (In Russ).

[76] Кочергин Н.Г., Смирнова Л.М., Кочергин С.Н. Итоги Первой всемирной конференции по псориазу и псориатическому артриту//Российский медицинский журнал. 2006. № 15. С. 1151.

[77] Adaskevich VP. Diagnostic indexes in dermatology. Moscow: BINOM; 2014. 341 с. (In Russ).

[78] Адаскевич В.П. Диагностические индексы в дерматологии. Москва: БИНОМ, 2014. 341 с.

RIGHTS & PERMISSIONS

Eco-Vector